The effect of ginger powder supplementation on insulin resistance and glycemic indices in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial

Complementary Therapies in Medicine

Volumn 22, Issue 1, 2014, Pages 9-16

  Mozaffari Khosravi, Hassan ^a   Talaei, Behrouz ^a   Jalali, Beman Ali ^a   Najarzadeh, Azadeh ^a   Mozayan, Mohammad Reza ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes mellitus; Ginger; Insulin resistance

Indexed keywords

DIABETES MELLITUS; GINGER; INSULIN RESISTANCE;

DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; GINGER; GLYCEMIC INDEX; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PLANT EXTRACTS; STATISTICS, NONPARAMETRIC;

EID: 84894236354     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2013.12.017     Document Type: Article

References (23)

1. Rathmann W., Giani G. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27(October (10)):2568-2569.
2. Hossain P., Kawar B., El N.M. Obesity and diabetes in the developing world - a growing challenge. N Engl J Med 2007, 356(January (3)):213-215.
3. Esteghamati A., Gouya M.M., Abbasi M., Delavari A., Alikhani S., Alaedini F., et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care 2008, 31(January (1)):96-98.
4. Esteghamati A., Meysamie A., Khalilzadeh O., Rashidi A., Haghazali M., Asgari F., et al. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health 2009, 9:167.
5. Afkhami-Ardekani M., Vahidi S., Vahidi A., Ahmadieh M. The prevalence of type 2 diabetes mellitus on age of 30 years and above in Yazd province (Iranian population). J Shahid Sadoughi Univ Med Sci 2001, 9(1):22-27.
6. minot-Gilchrist D.V., Anderson H.D. Insulin resistance-associated cardiovascular disease: potential benefits of conjugated linoleic acid. Am J Clin Nutr 2004, 79(June (6 Suppl.)):1159S-1163S.
7. Lipkin E. New strategies for the treatment of type 2 diabetes. J Am Diet Assoc 1999, 99(March (3)):329-334.
8. Flack J.M., Sowers J.R. Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia. Am J Med 1991, 91(July (1A)):11S-21S.
9. Gilani A.H., Rahman A.U. Trends in ethnopharmocology. J Ethnopharmacol 2005, 100(August (1-2)):43-49.
10. Thomson M., Al-Qattan K.K., Al-Sawan S.M., Alnaqeeb M.A., Khan I., Ali M. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins Leukot Essent Fatty Acids 2002, 67(December (6)):475-478.
11. Grzanna R., Lindmark L., Frondoza C.G. Ginger - an herbal medicinal product with broad anti-inflammatory actions. J Med Food 2005, 8(2):125-132.
12. Srivastava K.C. Aqueous extracts of onion, garlic and ginger inhibit platelet aggregation and alter arachidonic acid metabolism. Biomed Biochim Acta 1984, 43(8-9):S335-S346.
13. Srivastava K.C., Mustafa T. Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Med Hypotheses 1992, 39(December (4)):342-348.
14. Surh Y.J., Lee E., Lee J.M. Chemoprotective properties of some pungent ingredients present in red pepper and ginger. Mutat Res 1998, 402(June (1-2)):259-267.
15. Kiuchi F., Iwakami S., Shibuya M., Hanaoka F., Sankawa U. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull (Tokyo) 1992, 40(February (2)):387-391.
16. Zhang X.F., Tan B.K. Effects of an ethanolic extract of Gynura procumbens on serum glucose, cholesterol and triglyceride levels in normal and streptozotocin-induced diabetic rats. Singapore Med J 2000, 41(January (1)):9-13.
17. Shirdel Z., Mirbadalzadeh H., Madani H. Anti-diabetic and anti lipidemic properties of ginger in comparison glibenclamide in alloxan-diabetes rat. Iran J Diab Lipid Disorders 2009, 9(1):7-15.
18. Singh A., Akanksha, Singh N., Maurya R., Arvind Kumar S. Anti-hyperglycaemic, lipid lowering and anti-oxidant properties of 6-gingerol in db/db mice. Int J Med Sci 2009, 1(12):536-544.
19. Goyal R.K., Kadnur S.V. Beneficial effects of Zingiber officinale on goldthioglucose induced obesity. Fitoterapia 2006, 77(April (3)):160-163.
20. Mozaffari-Khosravi H., Hosseinzadeh-Shamsi-Anar M., Salami M.A., Hadinedoushan H., Mozayan M.R. Effects of a single post-partum injection of a high dose of vitamin D on glucose tolerance and insulin resistance in mothers with first-time gestational diabetes mellitus. Diab Med 2012, 29(January (1)):36-42.
21. Al-Amin Z.M., Thomson M., Al-Qattan K.K., Peltonen-Shalaby R., Ali M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br J Nutr 2006, 96(October (4)):660-666.
22. Bhandari U., Kanojia R., Pillai K.K. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol 2005, 97(February (2)):227-230.
23. Bordia A., Verma S.K., Srivastava K.C. Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 1997, 56(May (5)):379-384.